Welcome to our dedicated page for Future Health SEC filings (Ticker: FHLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Future Health's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Future Health's regulatory disclosures and financial reporting.
Form 25 filed to remove securities from Nasdaq. Future Health ESG Corp. (FHLT) submitted a Form 25 (Commission File No. 333-258911) to notify removal of its Common Stock, Units, and Warrants from listing on the Nasdaq Stock Market LLC. Issuer address is 8 The Green, Suite #12081, Dover, Delaware 19901; telephone listed as 8,333,888,734.
Regulatory statements and signature. The filing records that Nasdaq complied with 17 CFR 240.12d2-2(b) and that the issuer complied with 17 CFR 240.12d2-2(c) governing voluntary withdrawal. The notice is dated and signed on behalf of Nasdaq by Aravind Menon, Hearings Advisor, on 2025-08-08.